Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
neurodegenerative diseases
Research
Gain's clinical Parkinson's drug restores motor function in mice
The phase 1 drug for Parkinson’s disease that's associated with a common gene mutation restored motor function even after delay to treatment.
Helen Floersh
Feb 6, 2024 8:00am
Roche previews Alzheimer's drug that 'drops plaque like a stone'
Feb 1, 2024 11:30am
Alzheimer's transmission via procedure may boost prion theory
Jan 31, 2024 1:27pm
Merck seals $610M deal to acquire preclinical biotech Caraway
Nov 21, 2023 8:09am
CRL, Aitia form AI pact for oncology, neurology research
Nov 15, 2023 3:25pm
Cassava hints 'short-sellers' to blame for leaking CUNY report
Oct 13, 2023 9:46am